[_OS27] 一般口演27
AML

[OS27-3-3] RUNX1-RUNX1T1陽性AMLにおいてCD19陰性は予後不良因子となる-JPLSG AML05解析結果-
Negative CD19 expression is associated with inferior relapse free survival in RUNX1-RUNX1T1 positive AML; JPLSG experience from the AML-05 study

Kenichi Sakamoto^1,2,3, Norio Shiba⁴, Takao Deguchi^1,5, Nobutaka Kiyokawa⁶, Yoshiko Hashii⁷, Akiko Saito³, Daisuke Tomizawa¹, Takashi Taga⁸, Souichi Adachi⁹, Toshihiko Imamura² (1.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 2.Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.National Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 4.Department of Pediatrics, Yokohama City University Hospital, Graduate School of Medicine, Yokohama, Japan, 5.Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan, 6.Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan, 7.Department of Pediatrics, Osaka University, Osaka, Japan, 8.Department of Pediatrics, Shiga Medical University, Otsu, Shiga, Japan, 9.Department of Human Health Science, Kyoto University, Kyoto, Japan)